Accessing antiretroviral therapy following release from prison

JAMA

Volumn 301, Issue 8, 2009, Pages 848-857

  Baillargeon, Jacques ^a,b   Giordano, Thomas P ^c   Rich, Josiah D ^d   Wu, Z Helen ^a   Wells, Katherine ^e   Pollock, Brad H ^f   Paar, David P ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d BROWN UNIVERSITY   (United States)

^e TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CRIMINAL JUSTICE; ETHNICITY; FEMALE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PRESCRIPTION; PRIORITY JOURNAL; PRISON; PRISONER; RACE; RACE DIFFERENCE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT WITHDRAWAL; VIRUS LOAD; COHORT ANALYSIS; HEALTH CARE PLANNING; PATIENT; PATIENT COMPLIANCE; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; HEALTH PLANNING; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; PATIENT DROPOUTS; PRISONS; RETROSPECTIVE STUDIES; TEXAS; VIRAL LOAD; YOUNG ADULT;

EID: 61449162171     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.202     Document Type: Article

References (39)

1. Boutwell A, Rich JD. HIV infection behind bars. Clin Infect Dis. 2004;38(12):1761-1763.
2. Rich JD, Holmes L, Salas C, et al. Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health. 2001;78(2):279-289.
3. Dixon PS, Flanigan TP, DeBuono BA, et al. Infection with the human immunodeficiency virus in prisoners: meeting the health care challenge. Am J Med. 1993;95(6):629-635.
4. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;28(1):47-58.
5. Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004;38(12):1754-1760.
6. Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther. 2004;9(5):713-719.
7. Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120(1):84-88.
8. Mallik-Kane K, Visher CA. Health and Prisoner Reentry: How Physical, Mental, and Substance Abuse Conditions Shape the Process of Reintegration. Washington, DC: Urban Institute; 2008.
9. Baillargeon J, Binswanger IA, Penn JV, Williams BA, Murray OJ. Psychiatric disorders and repeat incarcerations: the revolving prison door. Am J Psychiatry. 2009;166(1):103-109.
10. Binswanger IA, Stern MF, Deyo RA, et al. Release from prison - a high risk of death for former inmates. N Engl J Med. 2007;356(2):157-165.
11. MacGowan RJ, Margolis A, Gaiter J, et al; Project START Study Group. Predictors of risky sex of young men after release from prison. Int J STD AIDS. 2003;14(8):519-523.
12. Morrow KM, Eldridge G, Nealey-Moore J, Grinstead O; Project START Study Group. HIV, STD, and hepatitis risk in the week following release from prison: an event-level analysis. J Correctional Health Care. 2007;13(1):27-38.
13. Baillargeon J, Borucki MJ, Zepeda S, Jenson HB, Leach CT. Antiretroviral prescribing patterns in the Texas prison system. Clin Infect Dis. 2000;31(6):1476-1481.
14. Wohl DA, Shain L, Adamian M, et al. HIV transmission risk behaviors among HIV-infected individuals released from prison. In: Program and abstracts of the 10th Conference on Retroviruses and Opportunistic Infections; February 10-14, 2003; Boston, MA. Abstract 36.
15. One in 100: behind bars in America 2008. Pew Center on the States Web site. http://www.pewcenteronthestates.org/report-detail.aspx?id=35904. Accessed September 1, 2008.
16. Raimer BG, Stobo JD. Health care delivery in the Texas prison system: the role of academic medicine. JAMA. 2004;292(4):485-489.
17. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Department of Health and Human Services Web site. http://www.aidsinfo.nih.gov/ ContentFiles/AdultandAdolescentGL.pdf. November 3, 2008. Accessed December 19, 2008.
18. An explanation of federal Medicaid and disability program rules. Council of State Governments Justice Center Web site. http://consensusproject.org/ projects/benefits/federal-benefits. Accessed December 15, 2008.
19. Stokes M, Davis CS, Koch GG. Categorical Data Analysis Using the SAS System. 2nd ed. Cary, NC: SAS Publishing; 2000.
20. Zhang J, Yu KF. What's the relative risk? a method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690- 1691.
21. Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998;17(14):1623-1634.
22. El-Sadr WM, Lundgren JD, Neaton JD, et al; Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283-2296.
23. Mumola CJ. Substance Abuse and Treatment, State and Federal Prisoners, 1997. Washington, DC: US Dept of Justice; 1999.
24. Pence BW, Miller WC, Gaynes BN, Eron JJ Jr. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;44(2):159-166.
25. Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998;279(24):1977-1983.
26. Kahn JG, Zhang X, Cross LT, Palacio H, Birkhead GS, Morin SF. Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S. Public Health Rep. 2002;117(3):252-262.
27. Menke TJ, Giordano TP, Rabeneck L. Utilization of health care resources by HIV-infected white, African-American, and Hispanic men in the era before highly active antiretroviral therapy. J Natl Med Assoc. 2003;95(9):853-861.
28. Palacio H, Kahn JG, Richards TA, Morin SF. Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep. 2002;117(3):233-251.
29. Glass TR, De Geest S, Weber R, et al. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2006;41(3):385-392.
30. Li X, Margolick JB, Conover CS, et al. Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2005;38(3):320-328.
31. Giordano TP, Visnegarwala F, White AC Jr, et al. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care. 2005;17(6):773-783.
32. Gardner LI, Metsch LR, Anderson-Mahoney P, et al; Antiretroviral Treatment and Access Study Study Group. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19(4):423-431.
33. Gordillo V, del Amo J, Soriano V, González-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13(13):1763-1769.
34. Shannon K, Kerr T, Lai C, et al. Nonadherence to antiretroviral therapy among a community with endemic rates of injection drug use. J Int Assoc Physicians AIDS Care. 2005;4(3):66-72.
35. Derlega VJ, Winstead BA, Brokington JE Jr. AIDS stigma among inmates and staff in a USA state prison. Int J STD AIDS. 2008;19(4):259-263.
36. Rao D, Pryor JB, Gaddist BW, Mayer R. Stigma, secrecy, and discrimination: ethnic/racial differences in the concerns of people living with HIV/AIDS. AIDS Behav. 2008;12(2):265-271.
37. Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS. 2006;20(5):359-368.
38. Maruschak LM. HIV in Prisons, 2005. Washington, DC: US Dept of Justice; 2007.
39. National ADAP Monitoring Project Annual Report, April 2008. Henry J. Kaiser Family Foundation, National Alliance of State and Territorial AIDS Directors. Kaiser Family Foundation Web site. http://www.kff.org/hivaids/ hiv040808pkg.cfm. Released April 8, 2008. Accessed December 18, 2008.